Stryker receives FDA clearance for OptaBlate™ Bone Tumor Ablation System
Stryker''s first bone tumor ablation system with patented microinfusion technology offers a reliable solution for people living with painful metastatic tumors PORTAGE, Mich., USA, Sept. 20, 2022 |PRNewswire| -- Stryker (NYSE:SYK), one of the world''s leading medical technology companies,…
Stryker receives FDA clearance for OptaBlate™ Bone Tumor Ablation System
Stryker''s first bone tumor ablation system with patented microinfusion technology offers a reliable solution for people living with painful metastatic tumors PORTAGE, Mich., USA, Sept. 20, 2022 |PRNewswire| -- Stryker (NYSE:SYK), one of the world''s leading medical technology companies,…